UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Quotient Wealth Partners LLC

Quotient Wealth Partners LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,574 shares of the healthcare conglomerate’s stock after selling 234 shares during the quarter. Quotient Wealth Partners LLC’s holdings in UnitedHealth Group were worth $1,808,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Genesee Capital Advisors LLC raised its position in UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC increased its position in UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after purchasing an additional 18 shares during the period. Powers Advisory Group LLC grew its holdings in UnitedHealth Group by 4.8% during the third quarter. Powers Advisory Group LLC now owns 418 shares of the healthcare conglomerate’s stock worth $244,000 after acquiring an additional 19 shares during the period. Wallace Capital Management Inc. grew its stake in shares of UnitedHealth Group by 0.9% during the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after purchasing an additional 19 shares during the period. Finally, Western Pacific Wealth Management LP boosted its holdings in UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after buying an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $526.68 on Friday. The firm’s fifty day simple moving average is $529.18 and its 200 day simple moving average is $564.30. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm has a market capitalization of $484.69 billion, a price-to-earnings ratio of 33.98, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the company posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on the company. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Morgan Stanley cut their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Oppenheimer upped their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.